Michael Lee Brooks - 16 Feb 2022 Form 4 Insider Report for Syneos Health, Inc.

Role: Chief Development Officer & Global Head Clinical Development Solutions
Signature: /s/ Jonathan Olefson, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 16 Feb 2022
Net transactions value: -$320,724
Form type: 4
Filing time: 18 Feb 2022, 16:07:00 UTC
Previous filing: 20 Jan 2022
Next filing: 04 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SYNH	Class A Common Stock	Tax liability	$320,724	-3,847	-9.8%	$83.37	35,453	16 Feb 2022	Direct
holding	SYNH	Class A Common Stock						10,842	16 Feb 2022	By spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Development Officer & Global Head Clinical Development Solutions